Home/ Stocks/ TXMD

TherapeuticsMD, Inc.

TXMD XNAS

$2.30 -0.03 (-1.29%) ▼ 15-min delayed

Open

$2.29

High

$2.36

Low

$2.26

Volume

17.8K

Market Cap

$26.62M

About TherapeuticsMD, Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 1 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$784.0K	$152.0K	$0.01
Q2 2025	$952.0K	$551.0K	$0.05
Q1 2025	$393.0K	$-653,000	$-0.06
FY 2024	$1.76M	$-2,181,000	$-0.19

Ticker Daily Articles on TXMD

10 Penny Stock Mistakes That Blow Up Accounts (and How to Avoid Them)

Marcus Rivera · 3h ago · News

Get TXMD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on TherapeuticsMD, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.